Clinical Trial Update: Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating afatinib after chemoradiation and surgery in high-risk stage III-IV head and neck squamous cell carcinoma (HNSCC); trial terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2016-04-04